The British Pound Suddenly Reverses Course

Perhaps as a great irony, the British pound (FXB) is suddenly losing favor even as the euro appears to stabilize in the wake of the latest drama in Greece. Since touching the 0.70 level last week, the euro has made steady gains against the British pound as seen here in EUR/GBP. Now, the British pound … Read more

The United States Oil Fund Flirts With A Breakdown

A little over two weeks ago I generated some simple trading scenarios for the United States Oil Fund LP (USO). The scenarios depended upon well-behaved volatility for oil, the CBOE Crude Oil ETF Volatility Index (OVX). OVX is now on the edge of breaking out above its 50-day moving average (DMA). The move was led … Read more

T2108 Update (June 19, 2015) – Embracing the Chop

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

The Euro’s Latest Breakdown Takes It To the Edge of A Larger Sell-Off

On Thursday night, May 21st, I observed the daily chart of the euro (FXE) and concluded it was ready for the next swoosh downward against the U.S. dollar. I posted this opinion on Stocktwits coincidentally at the same time someone else posted the exact opposite opinion. Source: StockTwits.com As it turned out, we were both … Read more

Charts to Trade: HDP, ISRG, FTNT, BOX, WIX

This is a quick post on five charts that caught my eye on Tuesday, May 19th. All charts annotated at and downloaded from FreeStockCharts.com. Hortonworks, Inc. (HDP) has struggled to make a good post-IPO impression. The first earnings report underwhelmed and led to a fresh all-time low. The last earnings report was initially well-received and … Read more

T2108 Update (May 15, 2015) – Chopped Into Another Marginal All-Time High

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (May 5, 2015) – Broken Record: Chopfest Continues

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (March 10, 2015) – Selling Intensifies With A Rush From Tech And A Parabolic Dollar

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (February 5, 2015) – A Continued Surge Toward Overbought Conditions

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

Intercept Pharmaceuticals Raises Much Needed Cash As Shorts Accelerate Their Bets

After the market closed for trading on January 29, 2015, Intercept Pharmaceuticals (ICPT) released exciting news: ICPT’s “…investigational product obeticholic acid (OCA) has received “breakthrough therapy designation” from the U.S. Food and Drug Administration (FDA) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis. This indication constitutes a population of patients with … Read more